Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
13-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #1461
advertisement
Clinical Ophthalmology
20
Showing records 1 to 20 |
Display all abstracts in
Clinical Ophthalmology
28146
International vision requirements for driver licensing and disability pensions: Using a milestone approach in characterization of progressive eye disease
Bron AM; Viswanathan AC; Thelen U; De Natale R; Ferreras A; Gundgaard J; Schwartz G; Buchholz P
Clinical Ophthalmology
2010; 4: 1361-1369
28153
A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost
Craven ER; Liu C-C; Batoosingh A; Schiffman RM; Whitcup SM
Clinical Ophthalmology
2010; 4: 1433-1440
28151
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
Katz G; Springs CL; Craven ER; Montecchi-Palmer M
Clinical Ophthalmology
2010; 4: 1253-1261
28138
Central corneal thickness in black Cameroonian ocular hypertensive and glaucomatous subjects
Noche CD; Eballe AO; Bella AL
Clinical Ophthalmology
2010; 4: 1371-1377
28141
Optic nerve head analysis of superior segmental optic hypoplasia using Heidelberg retina tomography
Miki A; Shirakashi M; Yaoeda K; Fukushima A; Takagi M; Abe H
Clinical Ophthalmology
2010; 4: 1193-1199
28142
Progression rate of total, and upper and lower visual field defects in open-angle glaucoma patients
Fukuchi T; Yoshino T; Sawada H; Seki M; Togano T; Tanaka T; Ueda J; Abe H
Clinical Ophthalmology
2010; 4: 1315-1323
28156
Viscogonioplasty in narrow angle glaucoma: A randomized controlled trial
Varma D; Adams W; Bunce C; Phelan P; Fraser S
Clinical Ophthalmology
2010; 4: 1475-1479
28152
Pigment dispersion syndrome associated with intraocular lens implantation: A new surgical technique
Jordana MIC; Formigo DP; Gonzalez RA; Reus JN
Clinical Ophthalmology
2010; 4: 1263-1266
28143
Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma
Shazly TA; Smith J; Latina MA
Clinical Ophthalmology
2011; 5: 5-10
28154
Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion
Kodama A; Sugioka K; Kuniyoshi K; Okuyama S; Matsumoto C; Shimomura Y
Clinical Ophthalmology
2010; 4: 1177-1180
28157
Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up
Allegri P; Mastromarino A; Neri P
Clinical Ophthalmology
2010; 4: 1201-1206
28155
Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
Miyashiro MJ; Lo SC; Stewart JA; Stewart WC
Clinical Ophthalmology
2010; 4: 1355-1359
28145
Paired-eye comparison of medical therapies for glaucoma
Solish AM; James F; Walt JG; Chiang TH
Clinical Ophthalmology
2010; 4: 1131-1135
28147
Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: Patient considerations
Suzuki Jr ER; Suzuki CLB
Clinical Ophthalmology
2010; 4: 1165-1171
28149
Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
Pozarowska D
Clinical Ophthalmology
2010; 4: 1229-1236
28150
Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
Schnober D; Hofmann G; Maier H; Scherzer M-L; Ogundele AB; Jasek MC
Clinical Ophthalmology
2010; 4: 1459-1463
28148
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
Bell NP; Ramos JL; Feldman RM
Clinical Ophthalmology
2010; 4: 1331-1346
28144
Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
Brief G; Lammich T; Nagel E; Pfennigsdorf S; Spraul CW; Ho S
Clinical Ophthalmology
2010; 4: 1125-1129
28139
Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire
Nordmann J-P; Baudouin C; Renard J-P; Denis P; Regnault A; Berdeaux G
Clinical Ophthalmology
2010; 4: 1489-1496
28140
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
Schmier JK; Lau EC; Covert DW
Clinical Ophthalmology
2010; 4: 1137-1143
Issue
13-1
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement